The problem with sublobar resections

There is a heightened interest in the oncologic efficacy of lobectomy versus sublobar resection in the treatment of early-stage non-small cell lung cancer (NSCLC), as demonstrated by an exponential increase in the number of publications on this topic in recent years (Figure 1).